Cryoport, Inc. will provide global logistics support to International Stem Cell Corp.’s (ISCO) for its Phase I trial in Australia for the treatment of moderate to severe Parkinson’s disease. ISCO recently began patient enrollment.   Two of Cryoport’s depots in southern California and Singapore, will provide logistics support for the study from ISCO’s research facility in California to the study site in Australia. Cryoport specializes in the movement of high-value biolog...